Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Danish Nested Case-Control Study

por Rikke Viggers, Rikke Viggers, Zheer Al-Mashhadi, Zheer Al-Mashhadi, Jakob Starup-Linde, Jakob Starup-Linde, Peter Vestergaard, Peter Vestergaard
Publicado 2021

Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.

por Viktoria Papp, Mathias Due Buron, Volkert Siersma, Peter Vestergaard Rasmussen, Zsolt Illes, Matthias Kant, Claudia Hilt, Zsolt Mezei, Homayoun Roshanisefat, Tobias Sejbæk, Arkadiusz Weglewski, Janneke van Wingerden, Svend Sparre Geertsen, Stephan Bramow, Finn Sellebjerg, Melinda Magyari
Publicado 2021